| Online-Ressource |
Verfasst von: | Turco, Verena [VerfasserIn]  |
| Pfleiderer, Kira [VerfasserIn]  |
| Hunger, Jessica [VerfasserIn]  |
| Horvat, Natalie [VerfasserIn]  |
| Karimian-Jazi, Kianush [VerfasserIn]  |
| Schregel, Katharina [VerfasserIn]  |
| Fischer, Manuel [VerfasserIn]  |
| Brugnara, Gianluca [VerfasserIn]  |
| Jähne, Kristine [VerfasserIn]  |
| Sturm, Volker Jörg Friedrich [VerfasserIn]  |
| Streibel, Yannik [VerfasserIn]  |
| Nguyen, Duy [VerfasserIn]  |
| Altamura, Sandro [VerfasserIn]  |
| Agardy, Dennis [VerfasserIn]  |
| Soni, Shreya S. [VerfasserIn]  |
| Alsasa, Abdulrahman [VerfasserIn]  |
| Bunse, Theresa [VerfasserIn]  |
| Schlesner, Matthias [VerfasserIn]  |
| Muckenthaler, Martina [VerfasserIn]  |
| Weissleder, Ralph [VerfasserIn]  |
| Wick, Wolfgang [VerfasserIn]  |
| Heiland, Sabine [VerfasserIn]  |
| Vollmuth, Philipp [VerfasserIn]  |
| Bendszus, Martin [VerfasserIn]  |
| Rodell, Christopher B. [VerfasserIn]  |
| Breckwoldt, Michael O. [VerfasserIn]  |
| Platten, Michael [VerfasserIn]  |
Titel: | T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles |
Verf.angabe: | Verena Turco, Kira Pfleiderer, Jessica Hunger, Natalie K. Horvat, Kianush Karimian-Jazi, Katharina Schregel, Manuel Fischer, Gianluca Brugnara, Kristine Jähne, Volker Sturm, Yannik Streibel, Duy Nguyen, Sandro Altamura, Dennis A. Agardy, Shreya S. Soni, Abdulrahman Alsasa, Theresa Bunse, Matthias Schlesner, Martina U. Muckenthaler, Ralph Weissleder, Wolfgang Wick, Sabine Heiland, Philipp Vollmuth, Martin Bendszus, Christopher B. Rodell, Michael O. Breckwoldt & Michael Platten |
E-Jahr: | 2023 |
Jahr: | 11 February 2023 |
Umfang: | 15 S. |
Fussnoten: | Gesehen am 28.09.2023 |
Titel Quelle: | Enthalten in: Nature Communications |
Ort Quelle: | [London] : Springer Nature, 2010 |
Jahr Quelle: | 2023 |
Band/Heft Quelle: | 14(2023), Artikel-ID 771, Seite 1-15 |
ISSN Quelle: | 2041-1723 |
Abstract: | Glioblastoma, the most common and aggressive primary brain tumor type, is considered an immunologically “cold” tumor with sparse infiltration by adaptive immune cells. Immunosuppressive tumor-associated myeloid cells are drivers of tumor progression. Therefore, targeting and reprogramming intratumoral myeloid cells is an appealing therapeutic strategy. Here, we investigate a β-cyclodextrin nanoparticle (CDNP) formulation encapsulating the Toll-like receptor 7 and 8 (TLR7/8) agonist R848 (CDNP-R848) to reprogram myeloid cells in the glioma microenvironment. We show that intravenous monotherapy with CDNP-R848 induces regression of established syngeneic experimental glioma, resulting in increased survival rates compared with unloaded CDNP controls. Mechanistically, CDNP-R848 treatment reshapes the immunosuppressive tumor microenvironment and orchestrates tumor clearing by pro-inflammatory tumor-associated myeloid cells, independently of T cells and NK cells. Using serial magnetic resonance imaging, we identify a radiomic signature in response to CDNP-R848 treatment and ultrasmall superparamagnetic iron oxide (USPIO) imaging reveals that immunosuppressive macrophage recruitment is reduced by CDNP-R848. In conclusion, CDNP-R848 induces tumor regression in experimental glioma by targeting blood-borne macrophages without requiring adaptive immunity. |
DOI: | doi:10.1038/s41467-023-36321-6 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1038/s41467-023-36321-6 |
| Volltext: https://www.nature.com/articles/s41467-023-36321-6 |
| DOI: https://doi.org/10.1038/s41467-023-36321-6 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | CNS cancer |
| Immunotherapy |
| Monocytes and macrophages |
| Neuroimmunology |
K10plus-PPN: | 1860407021 |
Verknüpfungen: | → Zeitschrift |
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles / Turco, Verena [VerfasserIn]; 11 February 2023 (Online-Ressource)